Trial intelligence / Profile preview

NPL-2009 in adults with Fragile X Syndrome

NCT00637221Phase 2Completed

Sponsor
Neuropharm
Start
Mar 2008
Primary completion
Apr 2008
Countries
1
01

Overview

A Phase 2 trial of fenobam in Fragile X syndrome (FXS), sponsored by Neuropharm. Started Mar 2008; status: completed.

02

Drugs

fenobam
03

Conditions

Fragile X syndrome (FXS)

Beyond the preview

Go deeper on NCT00637221.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00637221.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call